Receptor Life Sciences is entering a growing market

[mnholdem]

Medical Cannabis Sales are Projected to Rise on a Global Level
Published: Jun 01, 2018

Excerpt:

NEW YORK, June 1, 2018 /PRNewswire/ -- According to a research report published by Oristep Consulting, the global medical cannabis market in 2016 was valued at USD 12.67 billion and will reach USD 33.41 billion by 2022 at a CAGR of 17.53% during the forecasted period. Scientific studies of the cannabinoid chemical have already resulted in two FDA-approved medications in a pill form. The two main cannabinoids are THC and CBD, which are known to be used for medical purposes as treatments for numerous conditions such as multiple sclerosis, arthritis, epilepsy, glaucoma, HIV, chronic pain, Alzheimer's, cancer and others. The report also indicates that North America leads the market holding nearly half of the market share in 2016. Snipp Interactive Inc. (OTC: SNIPF), PotNetwork Holdings, Inc. (OTC: POTN), InMed Pharmaceuticals Inc. (OTC: IMLFF), Namaste Technologies Inc. (OTC: NXTTF), Kaya Holdings, Inc. (OTC: KAYS).

In a report by Benzinga, Viridian Capital President Scott Greiper points out that the cannabis market received $1.23 billion investments in the first five weeks of 2018, up from $178 million a year earlier.

Source: www.biospace.com/article/releases/medical-cannabis-sales-are-projected-to-rise-on-a-global-level/

 

[sayhey24]

The big question is when are they going to have a product to sell?

[dreamboatcruise]

Jun 3, 2018 7:59:10 GMT -5 sayhey24 said:

The big question is when are they going to have a product to sell?

If they are going for an FDA approved drug it would be years away still.